Physician profile
Hailey Kay
NPI 1053195891
$1,701.42
in general payments reported to CMS, 2019-2025
20 companies · $966 in 2025
The $966 reported for 2025 was more than what 96% of Pediatrics (Nurse Practitioner) providers received nationally (typical 2025 total: $93.49).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2023: $16.34 · 2024: $719 · 2025: $966.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,701.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,701.42 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Kyowa Kirin, INC. | $241.10 | 2024-2025 | |
| Abiomed | $238.58 | 2024-2025 | Impella |
| Acadia Pharmaceuticals INC | $219.61 | 2024-2025 | Daybue |
| Silk Road Medical, INC. | $142.90 | 2024 | Enroute Transcarotid Neuroprotection System, Enroute Transcarotid Stent, Enroute Enflate Transcarotid Rx Balloon Dilatation Catheter |
| Boston Scientific Corporation | $141.57 | 2025 | Watchman Flx |
| Abbvie INC. | $124.82 | 2025 | |
| Astrazeneca Pharmaceuticals LP | $117.54 | 2025 | Tezspire |
| Amarin Pharma, INC. | $112.65 | 2025 | Vascepa |
| W. L. Gore & Associates, INC. | $91.99 | 2024 | Gore Viabahn Endoprosthesis With Heparin |
| Coloplast Corp | $38.55 | 2024 | |
| Cranial Technologies, INC | $37.83 | 2024 | Doc Band |
| Ironshore Pharmaceuticals INC. | $35.10 | 2023-2024 | Jornay Pm |
| Regeneron Healthcare Solutions, INC. | $33.06 | 2025 | Dupixent |
| Csl Behring | $23.45 | 2025 | Haegarda |
| Sanofi Pasteur INC. | $20.33 | 2024 |
Show all 20 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Genentech USA, INC. | $18.54 | 2025 | Xolair |
| Collegium Pharmaceutical, INC. | $17.66 | 2025 | Jornay Pm |
| Vertical Pharmaceuticals, LLC | $17.37 | 2024 | Relexxii |
| Lilly USA, LLC | $15.32 | 2025 | Ebglyss |
| Pfizer INC. | $13.45 | 2024 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Hailey Kay listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.